180 Wealth Advisors, LLC Astrazeneca PLC Transaction History

180 Wealth Advisors, LLC

$632 Million
Q4 2024

A detailed history of 180 Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 8,357 shares of AZN stock, worth $577,134. This represents 0.09% of its overall portfolio holdings.

Number of Shares

8,357

Previous 8,297 0.72%

Holding current value

$577,134

Previous $646,000 15.33%

% of portfolio

0.09%

Previous 0.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$63.2 - $79.58 $3,792 - $4,774	60 Added 0.72%	8,357 $547,000
Q3 2024 Oct 31, 2024	SELL	$76.67 - $87.62 $1,073 - $1,226	-14 Reduced 0.17%	8,297 $646,000
Q2 2024 Jul 16, 2024	BUY	$66.81 - $80.83 $1,336 - $1,616	20 Added 0.24%	8,311 $648,000
Q1 2024 Apr 15, 2024	BUY	$61.03 - $69.57 $22,459 - $25,601	368 Added 4.64%	8,291 $561,000
Q4 2023 Jan 24, 2024	BUY	$61.89 - $69.28 $95,991 - $107,453	1,551 Added 24.34%	7,923 $533,000
Q3 2023 Oct 31, 2023	BUY	$64.85 - $71.7 $74,253 - $82,096	1,145 Added 21.91%	6,372 $431,000
Q2 2023 Jul 11, 2023	BUY	$69.91 - $75.81 $3,285 - $3,563	47 Added 0.91%	5,227 $374,000
Q1 2023 Apr 07, 2023	BUY	$63.15 - $71.6 $18,439 - $20,907	292 Added 5.97%	5,180 $359,000
Q4 2022 Feb 02, 2023	SELL	$54.21 - $70.44 $92,753 - $120,522	-1,711 Reduced 25.93%	4,888 $331,000
Q3 2022 Oct 12, 2022	SELL	$53.02 - $135.75 $29,479 - $75,477	-556 Reduced 7.77%	6,599 $362,000
Q2 2022 Jul 11, 2022	SELL	$59.26 - $71.14 $17,185 - $20,630	-290 Reduced 3.9%	7,155 $472,000
Q1 2022 Apr 22, 2022	SELL	$55.72 - $67.12 $28,807 - $34,701	-517 Reduced 6.49%	7,445 $508,000
Q4 2021 Jan 26, 2022	BUY	$54.02 - $63.83 $68,389 - $80,808	1,266 Added 18.91%	7,962 $471,000
Q3 2021 Oct 28, 2021	BUY	$55.56 - $60.79 $14,778 - $16,170	266 Added 4.14%	6,696 $403,000
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $57,619 - $71,614	1,190 Added 22.71%	6,430 $363,000
Q1 2021 May 25, 2021	SELL	$47.16 - $54.44 $11,082 - $12,793	-235 Reduced 4.29%	5,240 $301,000
Q4 2020 Jan 27, 2021	BUY	$48.52 - $58.02 $265,647 - $317,659	5,475 New	5,475 $288,000
Q3 2019 Oct 22, 2019	SELL	$40.12 - $45.47 $502,783 - $569,830	-12,532 Closed	0 $0
Q2 2019 Aug 05, 2019	SELL	$37.28 - $41.68 $186,064 - $208,024	-4,991 Reduced 28.48%	12,532 $551,000
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $81,485 - $98,773	-2,296 Reduced 11.58%	17,523 $666,000
Q4 2018 Jan 15, 2019	SELL	$36.86 - $41.49 $3,501 - $3,941	-95 Reduced 0.48%	19,819 $784,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $304,879 - $348,384	-8,771 Reduced 30.58%	19,914 $788,000
Q2 2018 Aug 08, 2018	SELL	$34.55 - $37.05 $415,809 - $445,896	-12,035 Reduced 29.56%	28,685 $1.01 Million
Q1 2018 Jun 01, 2018	SELL	$32.97 - $36.63 $179,917 - $199,889	-5,457 Reduced 11.82%	40,720 $1.41 Million
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $1.48 Million - $1.61 Million	46,177	46,177 $1.6 Million

Others Institutions Holding AZN

# of Institutions

1,340

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $214B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.

Account

180 Wealth Advisors, LLC Astrazeneca PLC Transaction History